Clinical outcome in patients with hepatocellular carcinoma after living-donor liver transplantation

Table 5 Comparison of the Milan and Catholic Medical Center criteria

Criteria		Recurrence rate	P-value	5-yr DFS	P-value	5-yr survival	P-value
Milan criteria
Single	≤ 5 cm (n = 91)	13%	< 0.001	0.862	< 0.001	0.829	< 0.001
	> 5 cm (n = 12)	61.5%		0.333		0.333
No. 2 or 3	≤ 3 cm (n = 39)	9.8%	0.889	0.878	0.891	0.711	0.251
	> 3 cm (n = 22)	8.7%		0.848		0.747
Number	≤ 3 (n = 164)	15.4%	0.209	0.824	0.228	0.781	0.316
	> 3 (n = 47)	21.7%		0.737		0.698
CMC criteria
Size ≤ 5 cm	AFP ≤ 100 (n = 138)	9.6%	0.001	0.886	< 0.001	0.818	< 0.001
Size ≤ 5 cm	AFP > 100 (n = 52)	20.0%		0.765		0.749
Size > 5 cm	AFP ≤ 100 (n = 15)	38.9%		0.514		0.508
Size > 5 cm	AFP > 100 (n = 4)	75.0%		0		0

CMC: Catholic Medical Center; DFS: Disease free survival; AFP: Alpha fetoprotein (mg/dL).